Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

NCT00276302 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors
Soft Tissue Sarcomas

Interventions

DRUG: IPI-504

Sponsor

Infinity Pharmaceuticals, Inc.